Your browser doesn't support javascript.
loading
Focal epithelial hyperplasia by human papillomavirus (HPV)-32 misdiagnosed as HPV-16 and treated with combination of retinoids, imiquimod and quadrivalent HPV vaccine.
Gemigniani, Franco; Hernández-Losa, Javier; Ferrer, Berta; García-Patos, Vicente.
Afiliação
  • Gemigniani F; Department of Dermatology, Hospital Universitari Vall d'Hebron, Facultat de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Hernández-Losa J; Department of Pathology, Hospital Universitari Vall d'Hebron, Facultat de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Ferrer B; Department of Pathology, Hospital Universitari Vall d'Hebron, Facultat de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • García-Patos V; Department of Dermatology, Hospital Universitari Vall d'Hebron, Facultat de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
J Dermatol ; 42(12): 1172-5, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26047065
Focal epithelial hyperplasia (FEH) or Heck's disease is a rare, benign and asymptomatic mucosal proliferation associated with human papillomavirus (HPV) infection, mainly with genotypes 13 and 32. We report a florid case of FEH in an 11-year-old Haitian girl with systemic lupus erythematosus receiving immunosuppressive therapy. Cryotherapy was previously performed on numerous occasions with no results. We decided to prescribe a non-invasive and more comfortable treatment. A combination of topical retinoid and imiquimod cream was well tolerated and led to an important improvement. The evidence of infection by HPV-16 detected by polymerase chain reaction (PCR) technique, prompted us to prescribe the quadrivalent HPV vaccine (types 6, 11,16 and 18). Subsequent PCR sequencing with generic primers GP5-GP6 and further BLAST comparative analysis confirmed that genomic viral sequence in our case truly corresponded with HPV-32. This molecular misdiagnosis can be explained by the similarity between genomic sequences of both HPV-16 and -32 genotypes. At the 1-year follow up, we observed total clinical improvement and no recurrences of the disease. Complete healing in this case may correspond to a potential action of topical retinoid, imiquimod and the cross-protection mechanism of the quadrivalent HPV vaccine.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Papillomaviridae / Hiperplasia Epitelial Focal / Infecções por Papillomavirus / Papillomavirus Humano 16 Tipo de estudo: Diagnostic_studies Idioma: En Revista: J Dermatol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Papillomaviridae / Hiperplasia Epitelial Focal / Infecções por Papillomavirus / Papillomavirus Humano 16 Tipo de estudo: Diagnostic_studies Idioma: En Revista: J Dermatol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Espanha